EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Influence of Lipopolysaccharide-Interacting Peptides Fusion with Endolysin LysECD7 and Fatty Acid Derivatization on the Efficacy against Acinetobacter baumannii Infection In Vitro and In Vivo

Xiaowan Li, Wenwen Shangguan, Xiaoqian Yang, Xiaoyue Hu, Yanan Li, Wenjie Zhao, Meiqing Feng, Jun Feng

Viruses · 2024

DOI: 10.3390/v16050760 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Xiaowan Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Fudan University, Shanghai 201203, China. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Acinetobacter Infections, Anti-Bacterial Agents, Endopeptidases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acinetobacter baumannii has developed multiple drug resistances, posing a significant threat to antibiotic efficacy. LysECD7, an endolysin derived from phages, could be a promising therapeutic agent against multi-drug resistance A. baumannii. In this study, in order to further enhance the antibacterial efficiency of the engineered LysECD7, a few lipopolysaccharide-interacting peptides (Li5, MSI594 and Li5-MSI) were genetically fused with LysECD7. Based on in vitro antibacterial activity, the fusion protein Lys-Li5-MSI was selected for further modifications aimed at extending its half-life. A cysteine residue was introduced into Lys-Li5-MSI through mutation (Lys-Li5-MSIV12C), followed by conjugation with a C16 fatty acid chain via a protonation substitution reaction(V12C-C16). The pharmacokinetic profile of V12C-C16 exhibited a more favorable characteristic in comparison to Lys-Li5-MSI, thereby resulting in enhanced therapeutic efficacy against lethal A. baumannii infection in mice. The study provides valuable insights for the development of novel endolysin therapeutics and proposes an alternative therapeutic strategy for combating A. baumannii infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial AgentsEndopeptidasesLipopolysaccharidesRecombinant Fusion ProteinsAnimalsFemaleMiceDisease Models, AnimalFatty AcidsMice, Inbred BALB CMicrobial Sensitivity TestsPeptides

Stichwörter der Autor:innen

Acinetobacter baumanniiLPS-interacting peptidesLysECD7endolysinfatty acid derivatizationpharmacokinetic

Substanzen

Anti-Bacterial AgentsendolysinEndopeptidasesFatty AcidsLipopolysaccharidesPeptidesRecombinant Fusion Proteins

Autor:innen und Institutionen

  • School of Pharmacy, Fudan University, Shanghai 201203, China.
  • Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Nanjing 210046, China.
  • China State Institute of Pharmaceutical Industry, Shanghai 201203, China.

Zitieren

APA

Li, X., Shangguan, W., Yang, X., Hu, X., Li, Y., Zhao, W., Feng, M., & Feng, J. (2024). Influence of Lipopolysaccharide-Interacting Peptides Fusion with Endolysin LysECD7 and Fatty Acid Derivatization on the Efficacy against Acinetobacter baumannii Infection In Vitro and In Vivo. Viruses. https://doi.org/10.3390/v16050760

Vancouver

Li X, Shangguan W, Yang X, Hu X, Li Y, Zhao W, et al. Influence of Lipopolysaccharide-Interacting Peptides Fusion with Endolysin LysECD7 and Fatty Acid Derivatization on the Efficacy against Acinetobacter baumannii Infection In Vitro and In Vivo. Viruses. 2024. doi:10.3390/v16050760

BibTeX
@article{Li2024,
  author = {Li, Xiaowan and Shangguan, Wenwen and Yang, Xiaoqian and Hu, Xiaoyue and Li, Yanan and Zhao, Wenjie and Feng, Meiqing and Feng, Jun},
  title = {Influence of Lipopolysaccharide-Interacting Peptides Fusion with Endolysin LysECD7 and Fatty Acid Derivatization on the Efficacy against Acinetobacter baumannii Infection In Vitro and In Vivo},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16050760}
}
Kostenlos starten →